CBD Life Sciences (CBD Life Sciences) Cash-to-Debt : N/A (As of Sep. 2015)

CBD Life Sciences Cash-to-Debt Chart

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Cash-to-Debt	Get a 7-Day Free Trial											N/A	N/A	N/A	N/A	N/A

Competitive Comparison of CBD Life Sciences's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Cash-to-Debt falls into.

CBD Life Sciences Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

CBD Life Sciences's Cash to Debt Ratio for the fiscal year that ended in Dec. 2014 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

CBD Life Sciences's Cash to Debt Ratio for the quarter that ended in Sep. 2015 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences  (OTCPK:CBDLD) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

CBD Life Sciences Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description